121 related articles for article (PubMed ID: 24200756)
1. Evaluating the evidence on comparative effectiveness and value of management options for treatment-resistant depression.
Emond SK; Ollendorf DA; Colby JA; Reed SJ; Pearson SD
Postgrad Med; 2013 Nov; 125(6):7-16. PubMed ID: 24200756
[TBL] [Abstract][Full Text] [Related]
2. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
Nguyen KH; Gordon LG
Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model.
Vallejo-Torres L; Castilla I; González N; Hunter R; Serrano-Pérez P; Perestelo-Pérez L
Psychol Med; 2015 May; 45(7):1459-70. PubMed ID: 25354790
[TBL] [Abstract][Full Text] [Related]
5. Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.
Fitzgibbon KP; Plett D; Chan BCF; Hancock-Howard R; Coyte PC; Blumberger DM
Can J Psychiatry; 2020 Mar; 65(3):164-173. PubMed ID: 31801363
[TBL] [Abstract][Full Text] [Related]
6. Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol.
Bulteau S; Laurin A; Volteau C; Dert C; Lagalice L; Schirr-Bonnans S; Bukowski N; Guitteny M; Simons L; Cabelguen C; Pichot A; Tessier F; Bonnin A; Lepage A; ; ; Vanelle JM; Sauvaget A; Riche VP
Trials; 2020 Apr; 21(1):312. PubMed ID: 32248820
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore.
Zhao YJ; Tor PC; Khoo AL; Teng M; Lim BP; Mok YM
Neuromodulation; 2018 Jun; 21(4):376-382. PubMed ID: 29143405
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial.
Knapp M; Romeo R; Mogg A; Eranti S; Pluck G; Purvis R; Brown RG; Howard R; Philpot M; Rothwell J; Edwards D; McLoughlin DM
J Affect Disord; 2008 Aug; 109(3):273-85. PubMed ID: 18262655
[TBL] [Abstract][Full Text] [Related]
9. Management strategies for attention-deficit/hyperactivity disorder: a regional deliberation on the evidence.
Emond SK; Ollendorf DA; Colby JA; Reed SJ; Pearson SD
Postgrad Med; 2012 Sep; 124(5):58-68. PubMed ID: 23095426
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.
Blumberger DM; Mulsant BH; Fitzgerald PB; Rajji TK; Ravindran AV; Young LT; Levinson AJ; Daskalakis ZJ
World J Biol Psychiatry; 2012 Sep; 13(6):423-35. PubMed ID: 21736507
[TBL] [Abstract][Full Text] [Related]
11. Neurostimulation as an intervention for treatment resistant depression: From research on mechanisms towards targeted neurocognitive strategies.
De Raedt R; Vanderhasselt MA; Baeken C
Clin Psychol Rev; 2015 Nov; 41():61-9. PubMed ID: 25468571
[TBL] [Abstract][Full Text] [Related]
12. Treatment resistant depression--advances in somatic therapies.
Kennedy SH; Giacobbe P
Ann Clin Psychiatry; 2007; 19(4):279-87. PubMed ID: 18058285
[TBL] [Abstract][Full Text] [Related]
13. Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response.
Pallanti S; Di Rollo A; Antonini S; Cauli G; Hollander E; Quercioli L
Neuropsychobiology; 2012 Jun; 65(4):227-35. PubMed ID: 22653158
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
15. Transcranial magnetic stimulation for treatment resistant depression: six case reports and review.
Krisanaprakornkit T; Paholpak S; Tassaniyom K; Pimpanit V
J Med Assoc Thai; 2010 May; 93(5):580-6. PubMed ID: 20524444
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic application of repetitive transcranial magnetic stimulation for major depression].
Nakamura M
Seishin Shinkeigaku Zasshi; 2012; 114(11):1231-49. PubMed ID: 23367835
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and volumetric predictors of response to repetitive transcranial magnetic stimulation (rTMS) - a prospective follow-up study.
Furtado CP; Hoy KE; Maller JJ; Savage G; Daskalakis ZJ; Fitzgerald PB
Psychiatry Res; 2012 Apr; 202(1):12-9. PubMed ID: 22608156
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression.
Fitzgerald PB; Hoy K; Gunewardene R; Slack C; Ibrahim S; Bailey M; Daskalakis ZJ
Psychol Med; 2011 Jun; 41(6):1187-96. PubMed ID: 20925972
[TBL] [Abstract][Full Text] [Related]
19. Targeting treatment-resistant depression.
Mathys M; Mitchell BG
J Pharm Pract; 2011 Dec; 24(6):520-33. PubMed ID: 22095575
[TBL] [Abstract][Full Text] [Related]
20. Management of treatment-resistant depression.
Keitner GI; Mansfield AK
Psychiatr Clin North Am; 2012 Mar; 35(1):249-65. PubMed ID: 22370501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
